Civic AI
Procurement intelligence
Federal contract award
4570560561!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML
AMERISOURCEBERGEN DRUG CORP · Department of Defense
- Value
- $7,082
- Start
- Jan 20, 2026
- End
- Jan 21, 2026
- Action date
- Jan 20, 2026
- PIID
- SPE2D826FCN88
- Status
- completed
- NAICS
- 325411 · MEDICINAL AND BOTANICAL MANUFACTURING
- Place of performance
- CONSHOHOCKEN, PA
- Award type
- DELIVERY ORDER
Description
4570560561!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML
Need modifications, related awards, and vendor peers? Open the full award workspace.